An immunochromatographic detection device

By integrating sample loading, pretreatment, and detection into an immunochromatographic detection device, and utilizing a porous blood filtration membrane and piston assembly, the problems of cumbersome pretreatment and blood filtration membrane clogging in whole blood sample testing are solved, achieving efficient and accurate detection results.

CN224957947UActive Publication Date: 2026-11-10SUZHOU INST OF MEDICAL ENG CHINESE ACAD OF SCI ZHENGZHOU INST OF ENG TECH +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202522536382.6
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2025-11-28
Publication Date
2026-11-10
Estimated Expiration
2035-11-28

AI Technical Summary

Technical Problem

Existing immunochromatographic detection technologies involve cumbersome and time-consuming pretreatment procedures when processing whole blood samples, and the blood filtration membrane is easily blocked by red blood cells, affecting the detection speed and the accuracy of the results.

Method used

An immunochromatographic detection device is designed, comprising a shell, a blood filtration structure, and a piston assembly. It integrates sample loading, pretreatment, and detection structures. The shell is divided into first and second chambers by a porous blood filtration membrane and a support. The piston assembly controls the sample flow, achieving efficient filtration of blood cells and avoiding contamination from external pretreatment operations.

Benefits of technology

This improved the accuracy of test results, shortened the testing time, and ensured the efficiency of the testing process and the reliability of the results.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN224957947U_ABST
    Figure CN224957947U_ABST
Patent Text Reader

Abstract

This utility model discloses an immunochromatographic detection device, relating to the field of immunochromatographic detection technology. The immunochromatographic detection device of this utility model includes a shell, a blood filtration structure, and a piston assembly. The shell has a chamber, and the blood filtration structure is located in the chamber, dividing the chamber into a first chamber and a second chamber. The piston assembly is at least partially located in the first chamber. The device integrates the sample loading, pretreatment, and detection structures, which can avoid contamination caused by transfer operations when pretreatment is performed outside the detection device, thereby improving the accuracy of the detection results. Compared with adding a blood filtration structure to the test strip, this device has higher blood filtration efficiency and can shorten the detection time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This utility model relates to the field of immunochromatographic detection technology, and specifically to an immunochromatographic detection device. Background Technology

[0002] Immunochromatographic assays, as an important rapid detection technology, are used for the prevention and early qualitative diagnosis of various diseases. Most commercially available products are suitable for samples with low viscosity, such as urine, saliva, serum, and plasma. For whole blood samples, one approach is pretreatment before testing, such as centrifugation to separate large particles like blood cells or dilution of the sample solution. This method is cumbersome and time-consuming. Another approach is to modify the structure of the chromatographic test strip by adding a blood filtration membrane between the sample pad and the conjugate pad. However, this structure may allow impurities such as red blood cells in the blood to clog the filtration membrane, slowing down the chromatographic speed of the sample solution on the test strip, prolonging the overall detection time, and even potentially allowing the blood to pass through the filtration membrane, increasing background interference as the chromatography process continues and affecting the test results. Utility Model Content

[0003] To overcome the shortcomings of existing technologies, this invention provides an immunochromatographic detection device. Its core objective is to pretreat blood samples, removing large particulate impurities such as blood cells from the sample solution before immunochromatographic detection, thus reducing the impact of these impurities on the detection results. By integrating sample loading, pretreatment, and detection into a single unit, it avoids contamination caused by transfer operations when pretreatment is performed outside the detection device, thereby improving the accuracy of the detection results.

[0004] To achieve the above objectives, the present invention adopts the following technical solution: An immunochromatographic detection device includes a housing, a blood filtration structure, and a piston assembly.

[0005] The shell has a compartment, and the blood filtration structure is located in the compartment. The blood filtration structure divides the compartment into a first compartment and a second compartment. The piston assembly is located at least partially in the first compartment.

[0006] Furthermore, the piston assembly includes a handle, a connecting rod, and a piston. The handle is fixedly connected to the connecting rod, and the piston is fixedly connected to the connecting rod. The connecting rod is located between the handle and the piston, and the piston is located in the first chamber.

[0007] Furthermore, the blood filtration structure includes a support component and a blood filtration membrane, with the blood filtration membrane fixed to the support component.

[0008] Furthermore, the support components include a first support member and a second support member, with the blood filtration membrane fixed between the first support member and the second support member.

[0009] Furthermore, both the first and second support members have a porous structure.

[0010] Furthermore, the shell includes a liquid inlet channel that communicates with the first compartment.

[0011] Furthermore, the bottom end of the liquid inlet channel is configured with a porous channel structure, and the liquid inlet channel is connected to the first chamber through the porous channel.

[0012] Furthermore, a first opening is formed at the connection between the porous channel and the first compartment, and the first opening is located above the centerline of the first compartment.

[0013] Furthermore, the piston assembly includes a piston located within a first compartment, wherein the distance from the first opening to the top of the first compartment is greater than the length of the piston.

[0014] Furthermore, the first compartment includes an extension section and a connecting section. The extension section is vertically arranged, and the connecting section is located between the extension section and the blood filtration structure, and the connecting section is inclined.

[0015] Compared to existing technologies, this novel immunochromatographic detection device includes a housing, a blood filtration structure, and a piston assembly. The housing contains a chamber, and the blood filtration structure is located within the chamber, dividing it into a first chamber and a second chamber. The piston assembly is at least partially located within the first chamber. This novel immunochromatographic detection device integrates sample loading, pretreatment, and detection into a single unit. This avoids contamination caused by transfer operations when pretreatment is performed outside the detection device, thus improving the accuracy of the detection results. Furthermore, compared to adding a blood filtration structure to the test strip, this device has higher blood filtration efficiency and can shorten the detection time. Attached Figure Description

[0016] Figure 1 This is a schematic diagram of the detection device; Figure 2 for Figure 1 Exploded view of the detection device; Figure 3 for Figure 1 A cross-sectional view of the detection device; Figure 4 This is a schematic diagram of a blood filtration system; Figure 5 This is a schematic cross-sectional view of the bottom structure of the detection device.

[0017] In the diagram: 1. Shell; 11. Upper shell; 12. Lower shell; 2. Second sealing cap; 3. Piston assembly; 31. Handle; 32. Connecting rod; 33. Piston; 4. First sealing cap; 5. Blood filtration structure; 51. First support member; 52. Blood filtration membrane; 53. Second support member; 6. Test strip; 13. First chamber; 14. Second chamber; 21. Liquid inlet channel; 22. Porous channel; 23. First opening; 121. First chamber; 122. Second chamber; 123. First channel; 130. Extension section; 131. Connecting section. Detailed Implementation

[0018] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0019] It should be noted that when a component is said to be "fixed to" another component, it can be directly on the other component or it can be fixed through another intermediate component. When a component is said to be "connected to" another component, it can be directly connected to the other component or it may be fixed through another intermediate component. When a component is said to be "set on" another component, it can be set directly on the other component or it may be set through another intermediate component. The terms "vertical," "horizontal," "left," "right," and similar expressions used in this document are for illustrative purposes only.

[0020] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The term "and / or" as used herein includes any and all combinations of one or more of the associated listed items.

[0021] like Figure 1-3 An immunochromatographic detection device includes a housing 1, a second sealing cap 2, a piston assembly 3, a first sealing cap 4, and a blood filtration structure 5; The housing 1 includes an upper housing 11 and a lower housing 12. A chamber is provided within the housing 1, and a blood filtration structure 5 is located within the chamber. The blood filtration structure 5 divides the chamber into a first chamber 13 and a second chamber 14. The piston assembly 5 is at least partially located within the first chamber 13. The housing includes a liquid inlet channel 21, which communicates with the first chamber 13. The bottom end of the liquid inlet channel 21 is configured with a porous channel structure, and the liquid inlet channel 21 communicates with the first chamber 13 through a porous channel 22.

[0022] The piston assembly 3 includes a handle 31, a connecting rod 32, and a piston 33. The handle 31 is fixedly connected to the connecting rod 32, and the piston 33 is fixedly connected to the connecting rod 32. The connecting rod 32 is located between the handle 31 and the piston 33, and the piston 33 is located in the first chamber 13.

[0023] The blood filtration structure 5 includes a support component and a blood filtration membrane 52, which is fixed to the support component. The support component includes a first support member 51 and a second support member 53, and the blood filtration membrane 52 is fixed between the first support member 51 and the second support member 53. The first support member 51 and the second support member 53 have a porous structure.

[0024] The liquid inlet channel 21 has an opening at the top and is connected to the first chamber 13 at the bottom via a porous channel 22. A second sealing cap 2 is fitted at the opening of the liquid inlet channel 21. Both the first chamber 13 and the second chamber 14 in the upper shell 11 are vertically continuous structures. The second chamber 14 has a 4 at the top opening and is used to hold the test strip 6. The test strip 6 has a conventional structure in which a sample pad, a conjugate pad, a reaction membrane, and an absorbent pad are sequentially arranged on a support plate. The test strip 6 is placed in the second chamber 14 with the sample pad end facing down. The second chamber 14 is made transparent in the area corresponding to the control line C and the detection line T of the reaction membrane to facilitate observation of the test results. A first opening 23 is formed at the connection between the porous channel 22 and the first chamber 13. The first opening 23 is located above the centerline of the first chamber 13 so that there is enough space in the lower part of the first chamber 13 to store the sample. The first chamber 13 also leaves a certain space at the upper end of the opening. The piston 33 is located inside the first chamber 13. The distance from the first opening 23 to the top of the first chamber 13 is greater than the length of the piston 33. This ensures that when the piston assembly 5 is pulled upwards until the top of the piston 33 is flush with the upper opening of the first chamber 13, the bottom end of the piston 33 is still above the first opening 23. This prevents the piston 33 from blocking the sample liquid from flowing smoothly into the first chamber 13 through the inlet channel 21. At the same time, the above structural design ensures that the piston assembly 3 remains in the first chamber 13 throughout the entire process during use, without needing to be pulled out, which is convenient for operation.

[0025] The lower housing 12 can be tightly connected to the upper housing 11 by means of adhesive, snap-fit, welding, etc., ensuring a seamless connection between the upper housing 11 and the lower housing 12 and achieving a complete seal. Furthermore, the lower housing 12 is sequentially provided with a first chamber 121 and a second chamber 122. The upper opening of the first chamber 121 communicates with the lower opening of the first compartment 13, and the upper opening of the second chamber 122 communicates with the lower opening of the second compartment 14. The lower ends of the first chamber 121 and the second chamber 122 are connected by a first channel 123.

[0026] The blood filtration structure 5 is located in the lower shell 12, such as Figure 4 The blood filtration structure 5 includes a first support 51, a second support 53, and a blood filtration membrane 52 located between them. Both the first support 51 and the second support 53 are porous structures and are made of materials that are not easily deformed under stress, so as to provide support for the blood filtration membrane 52 and prevent the structure of the blood filtration membrane 52 from being damaged when a certain pressure is applied. The first support 51, the blood filtration membrane 52, and the second support 53 can be fixedly connected by adhesive or other means. The blood filtration structure 5 can be installed in the first chamber 121 or the second chamber 122 to filter the sample liquid containing blood cells, retaining the blood cells on the side of the first chamber 121, while the filtered sample liquid containing the target analyte, such as serum or plasma, flows into the second chamber 122 and is absorbed by the sample pad of the test strip 6 in the second compartment 14 for subsequent detection of the analyte.

[0027] like Figure 5 In a preferred embodiment, the first chamber 13 includes an extension section 130 and a connecting section 131. The extension section 130 is vertically arranged, and the connecting section 131 is located between the extension section 130 and the blood filtration structure 5, and the connecting section is inclined. The blood filtration structure 5 is disposed inside the second chamber 122, and the depth of the first chamber 121 is greater than that of the second chamber 122. The first channel 123 is inclined, wherein the upper end of the first channel 123 communicates with the bottom of the second chamber 122, and the lower end of the first channel 123 communicates with the bottom of the first chamber 121. The bottom of the first chamber 121 can be configured as a funnel-shaped structure with the tip pointing downwards. The above-mentioned structural configuration allows the sample liquid containing blood cells to pass through the blood filtration structure from bottom to top, while large particles such as blood cells are deposited under their own gravity at the bottom of the blood filtration structure 2, thereby avoiding the accumulation of red blood cells on the surface of the blood filtration structure and clogging of the blood filtration membrane as the filtration time increases, and accelerating the blood filtration speed.

[0028] Preferably, a vent hole may be provided on the first sealing cover 4.

[0029] This invention involves opening the second sealing cap 2 and pulling the piston assembly 3 upward to move the piston 33 to the upper part of the first opening 23. An appropriate amount of blood sample liquid is added to the first chamber 13 through the liquid inlet channel 21. Then, the second sealing cap 2 is closed, and the piston assembly 3 is pushed downward to increase the internal pressure of the first chamber 12, thereby driving the sample liquid through the blood filtration structure 5. Impurities such as blood cells are trapped in the first chamber 13, while the filtrate flows into the second chamber 14 and is absorbed by the sample pad of the test strip 6. After a certain reaction time, an immunochromatographic detection structure is obtained.

[0030] The above embodiments only illustrate several implementation methods of this utility model, and their descriptions are relatively specific and detailed, but they should not be construed as limiting the scope of the utility model patent. It should be noted that for those skilled in the art, several modifications and improvements can be made without departing from the concept of this utility model. These are all equivalent modifications and improvements made to the above embodiments based on the essential technology of this utility model, and all of these fall within the protection scope of this utility model.

Claims

1. An immunochromatographic detection device, comprising a housing, characterized in that: It also includes the blood filtration structure and piston assembly; The housing has a chamber, the blood filtration structure is located in the chamber, the blood filtration structure divides the chamber into a first chamber and a second chamber, and the piston assembly is at least partially located in the first chamber.

2. The immunochromatographic detection device according to claim 1, characterized in that: The piston assembly includes a handle, a connecting rod, and a piston. The handle is fixedly connected to the connecting rod, and the piston is fixedly connected to the connecting rod. The connecting rod is located between the handle and the piston, and the piston is located in the first chamber.

3. The immunochromatographic detection device according to claim 1, characterized in that: The blood filtration structure includes a support component and a blood filtration membrane, wherein the blood filtration membrane is fixed to the support component.

4. The immunochromatographic detection device according to claim 3, characterized in that: The supporting components include a first supporting member and a second supporting member, and the blood filtration membrane is fixed between the first supporting member and the second supporting member.

5. The immunochromatographic detection device according to claim 4, characterized in that: The first support member and the second support member are porous structures.

6. The immunochromatographic detection device according to claim 1, characterized in that: The housing includes a liquid inlet channel, which is connected to the first compartment.

7. The immunochromatographic detection device according to claim 6, characterized in that: The bottom end of the liquid inlet channel is configured with a porous channel structure, and the liquid inlet channel is connected to the first chamber through the porous channel.

8. The immunochromatographic detection device according to claim 7, characterized in that: The porous channel forms a first opening at the connection point with the first compartment, and the first opening is located above the centerline of the first compartment.

9. The immunochromatographic detection device according to claim 8, characterized in that: The piston assembly includes the piston, which is located within the first compartment, and the distance from the first opening to the top of the first compartment is greater than the length of the piston.

10. The immunochromatographic detection device according to claim 4, characterized in that: The first compartment includes an extension section and a connecting section. The extension section is vertically arranged, and the connecting section is located between the extension section and the blood filtration structure. The connecting section is inclined.